Cochrane · systematic review · CD010063
Chromium picolinate supplementation for overweight or obese adults
Tian, H, Guo, X, Wang, X, et al. · Cochrane Database of Systematic Reviews · 2013 · Cochrane Library
Metabolic and Endocrine DisordersAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
6
current version
GRADE rated
2
No studies
4
Included studies
NR
No studies 4 · 66.7%Ungraded 0 · 0%Very low 0 · 0%Low 2 · 33.3%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Comparison
Population: overweight or obese adults
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Health‐related quality of life | no estimate extracted | NR | No studies |
Adverse events | no estimate extracted | 3 studies · 189 participants | Low Downgraded: risk of bias |
Death from any cause | no estimate extracted | NR | No studies |
Morbidity | no estimate extracted | NR | No studies |
Weight loss [kg] | no estimate extracted | 6 studies · 392 participants | Low Downgraded: risk of bias, indirectness |
Socioeconomic effects | no estimate extracted | NR | No studies |